Major investor in Glaxosmithkline suggests chief executive’s days are numbered after company comes under siege from activist investor Elliott By Lucy White For The Daily Mail Published: 16:51 EDT, 16 April 2021 | Updated: 16:51 EDT, 16 April 2021 A major investor
